203 related articles for article (PubMed ID: 20091130)
1. Uptake of predictive testing among relatives of BRCA1 and BRCA2 families: a multicenter study in northeastern Spain.
Sanz J; Ramón y Cajal T; Torres A; Darder E; Gadea N; Velasco A; Fortuny D; López C; Fisas D; Brunet J; Alonso MC; Balmaña J
Fam Cancer; 2010 Sep; 9(3):297-304. PubMed ID: 20091130
[TBL] [Abstract][Full Text] [Related]
2. Genetic uptake in BRCA-mutation families is related to emotional and behavioral communication characteristics of index patients.
Landsbergen K; Verhaak C; Kraaimaat F; Hoogerbrugge N
Fam Cancer; 2005; 4(2):115-9. PubMed ID: 15951961
[TBL] [Abstract][Full Text] [Related]
3. Communication of BRCA1 and BRCA2 results to at-risk relatives: a cancer risk assessment program's experience.
Wagner Costalas J; Itzen M; Malick J; Babb JS; Bove B; Godwin AK; Daly MB
Am J Med Genet C Semin Med Genet; 2003 May; 119C(1):11-8. PubMed ID: 12704633
[TBL] [Abstract][Full Text] [Related]
4. Phenocopies in BRCA1 and BRCA2 families: evidence for modifier genes and implications for screening.
Smith A; Moran A; Boyd MC; Bulman M; Shenton A; Smith L; Iddenden R; Woodward ER; Lalloo F; Maher ER; Evans DG
J Med Genet; 2007 Jan; 44(1):10-15. PubMed ID: 17079251
[TBL] [Abstract][Full Text] [Related]
5. Communication about positive BRCA1 and BRCA2 genetic test results and uptake of testing in relatives in a diverse Asian setting.
Lee DS; Meiser B; Mariapun S; Hassan T; Yip CH; Mohd Taib NA; Teo SH; Thong MK; Yoon SY
J Genet Couns; 2021 Jun; 30(3):720-729. PubMed ID: 33245177
[TBL] [Abstract][Full Text] [Related]
6. Association between BRCA1 and BRCA2 mutations and cancer phenotype in Spanish breast/ovarian cancer families: implications for genetic testing.
de la Hoya M; Osorio A; Godino J; Sulleiro S; Tosar A; Perez-Segura P; Fernandez C; Rodríguez R; Díaz-Rubio E; Benítez J; Devilee P; Caldés T
Int J Cancer; 2002 Feb; 97(4):466-71. PubMed ID: 11802208
[TBL] [Abstract][Full Text] [Related]
7. Statewide Retrospective Review of Familial Pancreatic Cancer in Delaware, and Frequency of Genetic Mutations in Pancreatic Cancer Kindreds.
Catts ZA; Baig MK; Milewski B; Keywan C; Guarino M; Petrelli N
Ann Surg Oncol; 2016 May; 23(5):1729-35. PubMed ID: 26727920
[TBL] [Abstract][Full Text] [Related]
8. Facilitated cascade testing (FaCT): a randomized controlled trial.
Nitecki R; Moss HA; Watson CH; Urbauer DL; Melamed A; Lu KH; Lipkin SM; Offit K; Rauh-Hain JA; Frey MK
Int J Gynecol Cancer; 2021 May; 31(5):779-783. PubMed ID: 33443030
[TBL] [Abstract][Full Text] [Related]
9. Low frequency of recurrent BRCA1 and BRCA2 mutations in Spain.
Llort G; Muñoz CY; Tuser MP; Guillermo IB; Lluch JR; Bale AE; Franco MA
Hum Mutat; 2002 Mar; 19(3):307. PubMed ID: 11857748
[TBL] [Abstract][Full Text] [Related]
10. Five recurrent BRCA1/2 mutations are responsible for cancer predisposition in the majority of Slovenian breast cancer families.
Krajc M; Teugels E; Zgajnar J; Goelen G; Besic N; Novakovic S; Hocevar M; De Grève J
BMC Med Genet; 2008 Sep; 9():83. PubMed ID: 18783588
[TBL] [Abstract][Full Text] [Related]
11. Mutational analysis of the BRCA1-interacting genes ZNF350/ZBRK1 and BRIP1/BACH1 among BRCA1 and BRCA2-negative probands from breast-ovarian cancer families and among early-onset breast cancer cases and reference individuals.
Rutter JL; Smith AM; Dávila MR; Sigurdson AJ; Giusti RM; Pineda MA; Doody MM; Tucker MA; Greene MH; Zhang J; Struewing JP
Hum Mutat; 2003 Aug; 22(2):121-8. PubMed ID: 12872252
[TBL] [Abstract][Full Text] [Related]
12. Factors determining dissemination of results and uptake of genetic testing in families with known BRCA1/2 mutations.
Finlay E; Stopfer JE; Burlingame E; Evans KG; Nathanson KL; Weber BL; Armstrong K; Rebbeck TR; Domchek SM
Genet Test; 2008 Mar; 12(1):81-91. PubMed ID: 18373407
[TBL] [Abstract][Full Text] [Related]
13. Sex ratio distortion in offspring of families with BRCA1 or BRCA2 mutant alleles: an ascertainment bias phenomenon?
Balmaña J; Díez O; Campos B; Majewski M; Sanz J; Alonso C; Baiget M; Garber JE
Breast Cancer Res Treat; 2005 Aug; 92(3):273-7. PubMed ID: 16155798
[TBL] [Abstract][Full Text] [Related]
14. Familial breast cancer genetic testing in the West of Ireland.
McVeigh TP; Irwin R; Cody N; Miller N; McDevitt T; Sweeney KJ; Green A; Kerin MJ
Ir J Med Sci; 2014 Jun; 183(2):199-206. PubMed ID: 23884708
[TBL] [Abstract][Full Text] [Related]
15. Childhood cancer in families with and without BRCA1 or BRCA2 mutations ascertained at a high-risk breast cancer clinic.
Brooks GA; Stopfer JE; Erlichman J; Davidson R; Nathanson KL; Domchek SM
Cancer Biol Ther; 2006 Sep; 5(9):1098-102. PubMed ID: 16931905
[TBL] [Abstract][Full Text] [Related]
16. 'Indirect' BRCA1/2 testing: a useful approach in hereditary breast and ovarian cancer families without a living affected relative.
Cruger DG; Kruse TA; Gerdes AM
Clin Genet; 2005 Sep; 68(3):228-33. PubMed ID: 16098011
[TBL] [Abstract][Full Text] [Related]
17. BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes.
Berry DA; Iversen ES; Gudbjartsson DF; Hiller EH; Garber JE; Peshkin BN; Lerman C; Watson P; Lynch HT; Hilsenbeck SG; Rubinstein WS; Hughes KS; Parmigiani G
J Clin Oncol; 2002 Jun; 20(11):2701-12. PubMed ID: 12039933
[TBL] [Abstract][Full Text] [Related]
18. Cancer risks in first degree relatives of BRCA1 mutation carriers: effects of mutation and proband disease status.
Gronwald J; Huzarski T; Byrski B; Medrek K; Menkiszak J; Monteiro AN; Sun P; Lubinski J; Narod SA
J Med Genet; 2006 May; 43(5):424-8. PubMed ID: 16227521
[TBL] [Abstract][Full Text] [Related]
19. Uptake of hereditary breast/ovarian cancer genetic testing in a French national sample of BRCA1 families. The French Cancer Genetic Network.
Julian-Reynier C; Sobol H; Sévilla C; Noguès C; Bourret P;
Psychooncology; 2000; 9(6):504-10. PubMed ID: 11180585
[TBL] [Abstract][Full Text] [Related]
20. The impact of proband mediated information dissemination in families with a BRCA1/2 gene mutation.
Sermijn E; Goelen G; Teugels E; Kaufman L; Bonduelle M; Neyns B; Poppe B; De Paepe A; De Grève J
J Med Genet; 2004 Mar; 41(3):e23. PubMed ID: 14985394
[No Abstract] [Full Text] [Related]
[Next] [New Search]
